Home›Companies›Biotech & Pharma›Tempero Bio

Tempero Bio, Inc.

Updated Oct 27, 2026·Latest SEC filing Nov 4, 2025·Suggest an edit

About Tempero Bio

Tempero Bio is a private company based in Oakland, California, incorporated in 2020 in Delaware. It has reported $76,958,457 raised in one offering on Form D since November 2025.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Oct 30, 2024Nov 4, 2025$76,958,457fully sold23$3.3MEquity, Offering of Series B-1 Preferred Stock and Series B-2 Preferred Stock (collectively "Preferred Stock") and the underlying shares of Common Stock issuable upon conversion of Preferred Stock.Rule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Tempero Bio's Form D filed Nov 4, 2025.

CK
Christian Klee
Chief Financial Officer
JG
PJ
Paul Johnson
Executive officer and director
RD
Ricardo Dolmetsch
Executive officer and director
JS
Julie Shah
Executive officer
JJ

Sources

  1. SECTempero Bio, Inc. filing history